Search

Zhaoqing Wang Phones & Addresses

  • Princeton, NJ
  • Somerset, NJ
  • 79 Heath Ct, Pennington, NJ 08534 (609) 730-8181
  • Plainsboro, NJ
  • Piscataway, NJ

Resumes

Resumes

Zhaoqing Wang Photo 1

Biomarker Lead

View page
Location:
Princeton, NJ
Industry:
Pharmaceuticals
Work:
Bristol-Myers Squibb
Biomarker Lead
Skills:
Pharmaceutical Industry
Zhaoqing Wang Photo 2

Zhaoqing Wang

View page
Zhaoqing Wang Photo 3

Zhaoqing Wang

View page

Publications

Us Patents

Organic Anion Transport Proteins

View page
US Patent:
6692934, Feb 17, 2004
Filed:
May 19, 2000
Appl. No.:
09/575081
Inventors:
Todd G. Kirchgessner - North Wales PA
Bonnie Hsiang - Trenton NJ
Yingjie Zhu - Killingworth CT
Yuli Wu - Newtown PA
Zhaoqing Wang - Piscataway NJ
Jean S. Lynch - Ringoes NJ
Xin Huang - Cranbury NJ
Wen-Pin Yang - Princeton NJ
Assignee:
Bristol-Myers Squibb Co. - Princeton NJ
International Classification:
C12P 2106
US Classification:
435 691, 435 911, 4353201, 536 231, 536 235, 530350, 436504
Abstract:
The current invention discloses nucleic acid and amino acid sequences for novel organic anion transfer proteins (âOATPsâ). The invention encompasses the OATPs described herein, together with vectors containing the cDNA sequences, host cells containing the vectors and polypeptides having all or part of an OATP. Also encompasses are uses for OATPs for targeting drugs to specific organs and for modulating the concentration of endogenous substrates.

Organic Anion Transport Proteins

View page
US Patent:
7795392, Sep 14, 2010
Filed:
May 17, 2007
Appl. No.:
11/804103
Inventors:
Todd G. Kirchgessner - Flemington NJ, US
Bonnie Hsiang - Pennington NJ, US
Yingjie Zhu - Killingworth CT, US
Yuli Wu - Newtown PA, US
Zhaoqing Wang - Piscataway NJ, US
Jean S. Lynch - Ringoes NJ, US
Xin Huang - Princeton NJ, US
Wen-Pin Yang - Princeton NJ, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
C07K 1/00
C07K 14/00
C12P 21/06
C12P 21/04
US Classification:
530350, 435 691, 435 697
Abstract:
The current invention discloses nucleic acid and amino acid sequences for novel organic anion transfer proteins (“OATPs”). The invention encompasses the OATPs described herein, together with vectors containing the cDNA sequences, host cells containing the vectors and polypeptides having all or part of an OATP. Also encompasses are uses for OATPs for targeting drugs to specific organs and for modulating the concentration of endogenous substrates.

Assay For Assessing Heart Failure

View page
US Patent:
20220317133, Oct 6, 2022
Filed:
Jun 5, 2020
Appl. No.:
17/616296
Inventors:
- Herlev, DK
- Princeton NJ, US
- Philadelphia PA, US
David Gordon - Princeton NJ, US
Zhaoqing Wang - Princeton NJ, US
Julio Alonso Chirinos Medina - Garnet Valley PA, US
Assignee:
Nordic Bioscience A/S - Herlev
Bristol-Myers Squibb Company - Princeton NJ
The Trustees of the University of Pennsylvania - Philadelphia PA
International Classification:
G01N 33/68
Abstract:
A method of immunoassay for detecting and/or monitoring a cardiovascular disease in a patient and/or assessing the likelihood of or the severity of a cardiovascular disease in a patient, comprising contacting a biofluid sample from a patient with a monoclonal antibody that specifically binds to a C-terminal epitope of the C5 domain of the α3 chain of type VI collagen, and/or contacting a biofluid sample from the patient with a monoclonal antibody that specifically binds to a C-terminal neo-epitope of the N-terminal propeptide of type III collagen.
Zhaoqing Q Wang from Princeton, NJ, age ~53 Get Report